Virpax Pharmaceuticals, Inc. filed its 10-K on Mar 22, 2023 for the period ending Dec 31, 2022. In this report its auditor, EisnerAmper LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.29 USD | -24.67% | +6.02% | -28.46% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.46% | 3.56M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- VRPX Stock
- News Virpax Pharmaceuticals, Inc.
- Virpax Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt